Viewing Study NCT01182168


Ignite Creation Date: 2025-12-24 @ 5:33 PM
Ignite Modification Date: 2026-03-02 @ 10:34 PM
Study NCT ID: NCT01182168
Status: COMPLETED
Last Update Posted: 2016-03-31
First Post: 2010-08-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Gemcitabine and Split-Dose Cisplatin Plus Everolimus (RAD001) in Patients With Advanced Solid Tumor Malignancies
Sponsor:
Organization: